These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5805885)
1. [Low-molecular dextran in the treatment of cardiogenic shock]. Dyduszyński A Pol Tyg Lek; 1969 Jul; 24(27):1059-61. PubMed ID: 5805885 [No Abstract] [Full Text] [Related]
3. [Low molecular dextran in the treatment of shock not related to the primary loss of body fluids]. Dyduszyński A Pol Tyg Lek; 1969 Jan; 24(4):121-4. PubMed ID: 4887633 [No Abstract] [Full Text] [Related]
4. [Dextran 40,000 in the treatment of shock in myocardial infarct]. Sadowski Z; Giec L; Luczak J; Bielak J Pol Tyg Lek; 1975 Mar; 30(12):519-22. PubMed ID: 1118345 [No Abstract] [Full Text] [Related]
5. Clinical experience with low molecular weight dextran in acute myocardial infarction. Langsjoen PH J Miss State Med Assoc; 1969 Nov; 10(11):499-502. PubMed ID: 5352795 [No Abstract] [Full Text] [Related]
6. [Therapy of cardiogenic shock after heart infarct]. Nager F; Steinbrunn W Schweiz Med Wochenschr; 1967 Mar; 97(12):389-91. PubMed ID: 5587440 [No Abstract] [Full Text] [Related]
7. [Treatment of shock in myocardial infarct with dextran and noradrenaline]. Sedziwy L Wiad Lek; 1977 Jan; 30(1):31-5. PubMed ID: 835259 [No Abstract] [Full Text] [Related]
8. [Fast administration of low-molecular dextran to patients with myocardial infarct associated with hypotension and shock]. Gratsianskiĭ NA; Zimin IuV Kardiologiia; 1970 May; 10(5):21-35. PubMed ID: 5448940 [No Abstract] [Full Text] [Related]
9. Low-molecular weight dextran in treatment of shock not associated with primary loss of systemic fluids. Dyduszyński A Pol Med J; 1969; 8(5):1083-8. PubMed ID: 5383925 [No Abstract] [Full Text] [Related]
10. Cardiogenic shock in acute myocardial infarction. Dennison AD J Indiana State Med Assoc; 1968 Nov; 61(11):1537-9. PubMed ID: 5704471 [No Abstract] [Full Text] [Related]
11. Hypovolemia in shock due to acute myocardial infarction. Loeb HS; Pietras RJ; Tobin JR; Gunnar RM Circulation; 1969 Nov; 40(5):653-9. PubMed ID: 5377207 [No Abstract] [Full Text] [Related]
12. [Evaluation of indications for clinical use of dextran in the light of experiences of the Institute of Hematology]. Rudowski W Pol Tyg Lek; 1969 Jul; 24(27):1044-7. PubMed ID: 5805882 [No Abstract] [Full Text] [Related]
13. [Treatment of shock in asphyxia neonatorum using low molecular dextrans]. Büning M; Palitzsch D Ther Ggw; 1971 Dec; 110(12):1808-10 passim. PubMed ID: 5159399 [No Abstract] [Full Text] [Related]
14. The microcirculatory effects of dextran. Stalker AL J Pathol Bacteriol; 1967 Jan; 93(1):191-201. PubMed ID: 6029757 [No Abstract] [Full Text] [Related]
15. [Observation on the use of low-molecular weight dextran of Polish production in surgical practice]. Latawiec K; Obrowska D; Taczanowski W Pol Tyg Lek; 1969 Jul; 24(27):1054-5. PubMed ID: 5306695 [No Abstract] [Full Text] [Related]
16. [Clinical use of dextrans]. Gelin LE Pol Tyg Lek; 1969 Jul; 24(27):1041-4. PubMed ID: 5805881 [No Abstract] [Full Text] [Related]